One More Step!

Opening Recap Market Pulse: U.S. equities edged sideways yesterday as investors parsed uneven data from corporate America. Tech names managed a slight gain, though all

Introduction Revolution Medicines, Inc. (NASDAQ: RVMD) is a late-stage oncology biotech focused on targeting RAS-driven cancers (marketchameleon.com) (www.biospace.com). The company’s lead drug daraxonrasib (also known

Opening Recap Market Pulse: Equities bounced back into record territory as major indexes reclaimed pre-Iran conflict levels. Key Movers: AMC Robotics stunned Wall Street with